# Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured Td

> **NCT00601835** · PHASE4 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 3651 (actual)

## Conditions studied

- Diphtheria
- Tetanus

## Interventions

- **BIOLOGICAL:** Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine
- **BIOLOGICAL:** Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine

## Key facts

- **NCT ID:** NCT00601835
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2005-07
- **Final completion:** 2005-07
- **Target enrollment:** 3651 (ACTUAL)
- **Last updated:** 2016-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00601835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00601835, "Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured Td". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00601835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*